Expression of neurokinin A receptor mRNA in human nasal mucosa

Acta Oto-Laryngologica, Supplement

Volumn 124, Issue 553, 2004, Pages 85-89

  Shirasaki, Hideaki ^a,b   Kanaizumi, Etsuko ^a   Watanabe, Kazumasa ^a   Konno, Nobuhiro ^a   Sato, Jun ^a   Asakura, Kohji ^a   Kataura, Akikatsu ^a   Himi, Tetsuo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Nasal mucosa; Neurokinin A; NK2 receptor; Tachykinin

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; DIGOXIGENIN; MESSENGER RNA; NEUROKININ 2 RECEPTOR; RNA POLYMERASE; NEUROKININ A;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA TEMPLATE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOLECULAR PROBE; NOSE MUCOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA PROBE; ARTICLE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NOSE OBSTRUCTION; PHYSIOLOGY; TURBINATE;

GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; NASAL MUCOSA; NASAL OBSTRUCTION; NEUROKININ A; RECEPTORS, NEUROKININ-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TURBINATES;

EID: 4143051421     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: 10.1080/03655230410017733     Document Type: Conference Paper

References (14)

1. Guard S, Watson S. Tachykinin receptor subtypes: classification and membrane signaling mechanism. Neurochem Int 1991; 18: 149-65.
2. Holzer P. Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43: 143-201.
3. Stjärne P, Rinder J, Heden-Blomquist E, Cardell LO, Lundberg J, Zetterstrom O, et al. Capsaicin desensitization of the nasal mucosa reduces symptoms upon allergen challenge in patients with allergic rhinitis. Acta Otolaryngol (Stockh) 1998; 118: 235-9.
4. Stjärne P, Lundblad L, Änggård A, Lundberg JM. Local capsaicin treatment of the nasal mucosa reduces symptoms in patients with nonallergic nasal hyperreactivity. Am J Rhinol 1991; 5: 145-51.
5. Shirasaki H, Asakura K, Narita S, Kataura A. Expression of substance P (NK1) receptor mRNA in human nose. Acta Otolaryngol (Stockh) 1998; 118: 717-22.
6. Baraniuk JK, Lundgren JD, Mullol J, Okayama M, Merida M, Kaliner MA. Substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol 1991; 4: 228-36.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
8. Birk PE, Grimm PC. Rapid nonradioactive in situ hybridization for interleukin-2 mRNA with riboprobes generated using the polymerase chain reaction. J Immunol Methods 1994; 167: 83-9.
9. Gerard NP, Eddy RL, Shows TB, Gerard C. The human neurokinin A (Substance K) receptor. J Biol Chem 1990; 265: 20455-62.
10. Shirasaki H, Asakura K, Narita S, Watanabe M, Kataura A. The effects of NK1 receptor antagonists (FK224 and FK888) on agonist- and antigen-induced nasal microvascular leakage in guinea pigs. Inflamm Res 1997; 46: 28-31.
11. Kaise T, Akamatsu Y, Ikemura T, Ohmori K, Ishii A, Karasawa A. Involvement of neuropeptides in allergic nasal obstruction in guinea pigs. Jpn J Pharmacol 2001; 86: 196-202.
12. Bai TR, Zhou D, Weir T, Walker B, Hegele R, Hayashi S, et al. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 1995; 269: L309-17.
13. Evans TW, Dixon CM, Clarke B, Conradson TB, Barnes PJ. Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol 1988; 25: 272-5.
14. Braunstein G, Fajac I, Lacronique J, Frossard N. Clinical and inflammatory responses to exogenous tachykinin in allergic rhinitis. Am Rev Respir Dis 1991; 144: 630-5.